Al-Lamee Hannan, Stone Katie, Powell Simon G, Wyatt James, Drakeley Andrew J, Hapangama Dharani K, Tempest Nicola
Department of Women's and Children's Health, Centre for Women's Health Research, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool Health Partners, Liverpool, UK.
Hewitt Centre for Reproductive Medicine, Liverpool Women's NHS Foundation Trust, Liverpool, UK.
Hum Reprod Open. 2024 Jun 20;2024(3):hoae040. doi: 10.1093/hropen/hoae040. eCollection 2024.
Does endometrial compaction (EC) help predict pregnancy outcomes in those undergoing ART?
EC is associated with a significantly higher clinical pregnancy rate (CPR) and ongoing pregnancy rate (OPR), but this does not translate to live birth rate (LBR).
EC describes the progesterone-induced decrease in endometrial thickness, which may be observed following the end of the proliferative phase, prior to embryo transfer. EC is proposed as a non-invasive tool to help predict pregnancy outcome in those undergoing ART, however, published data is conflicting.
A literature search was carried out by two independent authors using PubMed, Cochrane Library, MEDLINE, Embase, Science Direct, Scopus, and Web of Science from inception of databases to May 2023. All peer-reviewed studies reporting EC and pregnancy outcomes in patients undergoing IVF/ICSI treatment were included.
PARTICIPANTS/MATERIALS SETTING METHODS: The primary outcome is LBR. Secondary outcomes included other pregnancy metrics (positive pregnancy test (PPT), CPR, OPR, miscarriage rate (MR)) and rate of EC. Comparative meta-analyses comparing EC and no EC were conducted for each outcome using a random-effects model if > 50%. The Mantel-Haenszel method was applied for pooling dichotomous data. Results are presented as odds ratios (OR) with 95% CI.
Out of 4030 screened articles, 21 cohort studies were included in the final analysis (n = 27 857). No significant difference was found between LBR in the EC versus the no EC group (OR 0.95; 95% CI 0.87-1.04). OPR was significantly higher within the EC group (OR 1.61; 95% CI 1.09-2.38), particularly when EC ≥ 15% compared to no EC (OR 3.52; 95% CI 2.36-5.23). CPR was inconsistently defined across the studies, affecting the findings. When defined as a viable intrauterine pregnancy <12 weeks, the EC group had significantly higher CPR than no EC (OR 1.83; 95% CI 1.15-2.92). No significant differences were found between EC and no EC for PPT (OR 1.54; 95% CI 0.97-2.45) or MR (OR 1.06; 95% CI 0.92-1.56). The pooled weighted incidence of EC across all studies was 32% (95% CI 26-38%).
Heterogeneity due to differences between reported pregnancy outcomes, definition of EC, method of ultrasound, and cycle protocol may account for the lack of translation between CPR/OPR and LBR findings; thus, all pooled data should be viewed with an element of caution.
In this dataset, the significantly higher CPR/OPR with EC does not translate to LBR. Although stratification of women according to EC cannot currently be recommended in clinical practice, a large and well-designed clinical trial to rigorously assess EC as a non-invasive predictor of a successful pregnancy is warranted. We urge for consistent outcome reporting to be mandated for ART trials so that data can be pooled, compared, and concluded on.
STUDY FUNDING/COMPETING INTERESTS: H.A. was supported by the Hewitt Fertility Centre. S.G.P. and J.W. were supported by the Liverpool University Hospital NHS Foundation Trust. D.K.H. was supported by a Wellbeing of Women project grant (RG2137) and MRC clinical research training fellowship (MR/V007238/1). N.T. was supported by the National Institute for Health and Care Research. D.K.H. had received honoraria for consultancy for Theramex and has received payment for presentations from Theramex and Gideon Richter. The remaining authors have no conflicts of interest to report.
PROSPERO CRD42022378464.
子宫内膜致密化(EC)是否有助于预测接受辅助生殖技术(ART)治疗者的妊娠结局?
EC与显著更高的临床妊娠率(CPR)和持续妊娠率(OPR)相关,但这并未转化为活产率(LBR)。
EC描述了孕激素诱导的子宫内膜厚度降低,这可能在增殖期结束后、胚胎移植前观察到。EC被提议作为一种非侵入性工具,以帮助预测接受ART治疗者的妊娠结局,然而,已发表的数据存在冲突。
研究设计、规模、持续时间:两名独立作者使用PubMed、Cochrane图书馆、MEDLINE、Embase、Science Direct、Scopus和Web of Science从数据库建立之初至2023年5月进行了文献检索。纳入了所有报告接受体外受精/卵胞浆内单精子注射(IVF/ICSI)治疗患者的EC和妊娠结局的同行评审研究。
参与者/材料、设置、方法:主要结局是LBR。次要结局包括其他妊娠指标(妊娠试验阳性(PPT)、CPR、OPR、流产率(MR))和EC发生率。如果I²>50%,则使用随机效应模型对每个结局进行比较EC和无EC的对比荟萃分析。采用Mantel-Haenszel方法汇总二分数据。结果以比值比(OR)及95%置信区间(CI)表示。
在4030篇筛选文章中,最终分析纳入了21项队列研究(n = 27857)。EC组与无EC组的LBR之间未发现显著差异(OR 0.95;95%CI 0.87 - 1.04)。EC组的OPR显著更高(OR 1.61;95%CI 1.09 - 2.38),特别是当EC≥15%时与无EC相比(OR 3.52;95%CI 2.36 - 5.23)。各研究中CPR的定义不一致,影响了研究结果。当定义为妊娠12周内的活胎宫内妊娠时,EC组的CPR显著高于无EC组(OR 1.83;95%CI 1.15 - 2.92)。EC和无EC在PPT(OR 1.54;95%CI 0.97 - 2.45)或MR(OR 1.06;95%CI 0.92 - 1.56)方面未发现显著差异。所有研究中EC的合并加权发生率为32%(95%CI 26 - 38%)。
局限性、谨慎的原因:由于报告的妊娠结局、EC的定义、超声方法和周期方案之间的差异导致的异质性,可能是CPR/OPR和LBR结果之间缺乏转化的原因;因此,所有汇总数据应谨慎看待。
在该数据集中,EC导致的显著更高的CPR/OPR并未转化为LBR。尽管目前在临床实践中尚不能建议根据EC对女性进行分层,但有必要开展一项大型且设计良好的临床试验,以严格评估EC作为成功妊娠的非侵入性预测指标。我们敦促ART试验强制要求一致的结局报告,以便能够汇总、比较和总结数据。
研究资金/利益冲突:H.A.得到休伊特生育中心的支持。S.G.P.和J.W.得到利物浦大学医院国民保健服务基金会信托基金的支持。D.K.H.得到女性健康项目资助(RG2137)和医学研究理事会临床研究培训奖学金(MR/V007238/1)。N.T.得到国家卫生与保健研究所的支持。D.K.H.曾因担任Theramex的顾问而获得酬金,并从Theramex和吉迪恩·里奇特公司获得演讲报酬。其余作者无利益冲突报告。
PROSPERO CRD42022378464